4 Nov 2008 07:00
4 November 2008 Source BioScience plc (`Source BioScience' or `the Company') Source BioScience Expands Distributor Network in East Asia
Source BioScience plc , the provider of expert, quality services to the healthcare, pharma biotech and life science research sector, is pleased to announce an expansion of its distributor network for its Geneservice and Autogen Bioclear life science research products and services in the East Asian market.
Source BioScience has also been appointed as a distributor, both in the UK and Europe, for a number of life science research product manufacturers, enhancing the portfolio of genomic reagents and antibodies that the Company offers.
HIGHLIGHTS
* Extended distributor network for genomic reagents into China, Hong Kong, Korea, Singapore and Malaysia * The Company will offer next generation DNA sequencing in Japan through a local distributor * Enhanced portfolio of genomic reagents and catalogue of antibodies following agreements with a number of new suppliers and manufacturers * Consolidates the expertise within the Geneservice and Autogen Bioclear businesses to accelerate the growth of its Life Science Research product and service portfolio
East Asian Distributors
Source BioScience has appointed a number of distributors for its Geneservice life science research products in the important East Asian market. In recent years there has been significant investment of both public and private funding into research in the life sciences, and in particular genomics, across many countries in this region.
EnoGene Biotech (`EnoGene') has been appointed in China and Hong Kong; Dynebio Company (`Dynebio') in Korea and Bio.Etc PTE Limited (`BioEtc') in Singapore and Malaysia. This network will distribute the Company's unique portfolio of Geneservice genomic reagents including the extensive range of RNAi and cDNA clones and libraries.
Source BioScience has also appointed Moritex Corporation (`Moritex') to be the exclusive Japanese distributor for the Company's Geneservice next generation DNA sequencing services on its Illumina Genome Analyser II platform.
Expanded Antibody Portfolio
Source BioScience now offers a catalogue in excess of 49,000 high quality antibodies following a number of new agreements signed with suppliers and manufacturers of genomic reagents and antibodies. The Company also anticipates adding a further 40,000 antibodies, optimised for immunohistochemistry, to its catalogue and which will be launched before the end of the year.
The Company now distributes antibodies for GeneTex Inc. and Enogene in the UK. Source BioScience has also signed supply agreements with a number of manufacturers to offer an increased range of antibodies under the Company's Autogen Bioclear own label. These agreements extend the range of research areas that the Company's portfolio now addresses as well as increasing the depth of product offering across the range.
Source BioScience has also enlarged its existing distribution agreement with Kabushiki Kaisha Dnaform (`KK DNAForm') of Japan to include the latest KK DNAForm cDNA libraries as well as the library construction services. Through Geneservice, Source BioScience already exclusively distributes the KKDNAForm FANTOM and DNABook cDNA libraries in the UK.
Dr Nick Ash, Managing Director of Source BioScience said "These new partnerships, and enlarged existing collaborations demonstrate the growing credibility that Source BioScience is receiving in the life science research market. We will continue building on these relationships in order to deliver an unrivalled portfolio of life science research services and products.
"The East Asia expansion of our distributor network is particularly exciting as we have historically found this emerging market for life science research products and services difficult to penetrate. We have reached agreements with a number of local distributors to offer our range of genomic reagents but also enable access to our next generation DNA sequencing technology."
- ENDS -
For further information, please contact:
Source BioScience plcDr Nick AshManaging DirectorTel: 0115 973 9010www.sourcebioscience.comBishopsgate CommunicationsNick Rome / Gemma O'HaraTel: 0207 562 3350www.bishopsgatecommunications.com
About Source BioScience:
Source BioScience plc is a highly focused healthcare and biotechnology company offering expert, quality services and products to the healthcare, pharma biotech and life science research sectors. Its Healthcare division provides the latest cytology screening equipment and techniques as well as diagnostic testing for cancer and other diseases, including predictive testing for treatment optimisation for clinicians and patients. Pharma Biotech Services offers support for early stage therapeutic development, offering a 'one-stop shop' from tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination and assay development to pharmacogenomics including genotyping and gene expression analysis. The Life Science Research division provides core laboratory research support from conceptualisation to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. This incorporates DNA sequencing, whole genome amplification and a comprehensive library of genomic reagents and clones including cDNA and RNAi, as well as facilitating rapid access to high quality antibodies, cell cultures, diagnostic assays for cancer and other genetic testing, and related research tools.
The Group has its headquarters in Nottingham where it operates state of the art reference laboratory facilities, with additional laboratory facilities in Cambridge and Oxford. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.
Further information is available on the Source BioScience website: www.sourcebioscience.com
vendor